Clinical Trials Logo

Uterine Leiomyoma clinical trials

View clinical trials related to Uterine Leiomyoma.

Filter by:

NCT ID: NCT02736435 Withdrawn - Uterine Leiomyoma Clinical Trials

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

Start date: January 18, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the effectiveness of MR-HIFU for the treatment of uterine fibroids in Northwestern Ontario, which is a rural and remote setting.

NCT ID: NCT02495311 Recruiting - Adenomyosis Clinical Trials

The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms

Start date: November 15, 2014
Phase:
Study type: Observational

The aim of this study is to assess the relationship between adenomyosis/myoma and lower urinary tract symptoms, sexual function and gastrointestinal symptoms.

NCT ID: NCT02059954 Completed - Uterine Fibroids Clinical Trials

Vaginal vs. Laparoscopic Hysterectomy

Start date: January 2014
Phase: N/A
Study type: Interventional

Hysterectomy for benign indication is one of the most common surgical procedures in women. Numerous reviews and guidelines recommend the vaginal approach for benign hysterectomy, but the proportion of laparoscopic (and robotic) hysterectomies is increasing. This study will compare a range of clinical and subjective outcomes of vaginal vs. total laparoscopic hysterectomy. Outcomes include operating time, postoperative recovery, return to work as well as cosmesis, quality of life and sexual health.

NCT ID: NCT02049242 Completed - Uterine Leiomyoma Clinical Trials

Uterine Tourniquet at Open Myomectomy

Start date: January 2014
Phase: N/A
Study type: Interventional

The aim of study is to compare triple tourniquet vs. single tourniquet to reduce blood loss at open myomectomy.

NCT ID: NCT01738724 Terminated - Uterine Leiomyoma Clinical Trials

Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin

Start date: January 2012
Phase: Phase 4
Study type: Interventional

The investigators´aim is to assess whether the progestagen dienogest reduces leiomyoma volume and its associated symptoms to the same extent as gonadotropin releasing hormone (GnRH) analogs or the progestagen desogestrel or whether it is inferior to other drugs already in use.

NCT ID: NCT01715597 Completed - Uterine Leiomyoma Clinical Trials

Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

Start date: December 2012
Phase: Phase 3
Study type: Interventional

The investigators want to know whether the intravenous ascorbic acid would reduce the blood loss during laparoscopic myoma surgery. The investigators randomized patients into intravenous ascorbic acid group and placebo group and examined the blood loss in both groups.

NCT ID: NCT01468402 Completed - Uterine Leiomyoma Clinical Trials

Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma

Start date: September 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine predictive factors in the pelvic magnetic resonance in the response of arterial embolization of uterine leiomyoma.

NCT ID: NCT01338831 Completed - Clinical trials for Metastatic Breast Cancer

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

Start date: September 2011
Phase: Phase 1
Study type: Interventional

The purpose of this first multi-dose study in cancer patients is to determine the maximum tolerated dose (MTD) or recommended phase II dose (RP2D), characterize the safety, tolerability and pharmacokinetics profile. Once the MTD has been established and/or a RP2D chosen, the study will enroll patients into the expansion portion of the study.

NCT ID: NCT01280045 Terminated - UTERINE LEIOMYOMA Clinical Trials

Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy

Start date: January 2011
Phase: N/A
Study type: Interventional

The investigators aimed to assess if use of aromatase inhibitors could decrease volume of uterine leiomyoma and cause same percentage of adverse effects during its use compared to GnRH analogs.

NCT ID: NCT00365989 Completed - Uterine Fibroids Clinical Trials

MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication

Start date: October 2006
Phase: Phase 3
Study type: Interventional

This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.